NDC 0944-3026

RIXUBIS

Coagulation Factor Ix (recombinant)

RIXUBIS is a Kit in the Plasma Derivative category. It is labeled and distributed by Baxalta Us Inc.. The primary component is .

Product ID0944-3026_1559c673-105b-4fea-b3a7-b6f4bf39b6e2
NDC0944-3026
Product TypePlasma Derivative
Proprietary NameRIXUBIS
Generic NameCoagulation Factor Ix (recombinant)
Dosage FormKit
Marketing Start Date2013-10-04
Marketing CategoryBLA / BLA
Application NumberBLA125446
Labeler NameBAXALTA US INC.
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0944-3026-02

1 KIT in 1 CARTON (0944-3026-02) * 5 mL in 1 VIAL, GLASS (0944-3025-01) * 5 mL in 1 VIAL, GLASS
Marketing Start Date2013-10-04
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0944-3026-02 [00944302602]

RIXUBIS KIT
Marketing CategoryBLA
Application NumberBLA125446
Product TypePLASMA DERIVATIVE
Billing UnitEA
Marketing Start Date2013-10-04

Drug Details

NDC Crossover Matching brand name "RIXUBIS" or generic name "Coagulation Factor Ix (recombinant)"

NDCBrand NameGeneric Name
0944-3026RIXUBISCOAGULATION FACTOR IX (RECOMBINANT)
0944-3028RIXUBISCOAGULATION FACTOR IX (RECOMBINANT)
0944-3030RIXUBISCOAGULATION FACTOR IX (RECOMBINANT)
0944-3032RIXUBISCOAGULATION FACTOR IX (RECOMBINANT)
0944-3034RIXUBISCOAGULATION FACTOR IX (RECOMBINANT)
58394-633BeneFIXcoagulation factor ix (recombinant)
58394-634BeneFIXcoagulation factor ix (recombinant)
58394-635BeneFIXcoagulation factor ix (recombinant)

Trademark Results [RIXUBIS]

Mark Image

Registration | Serial
Company
Trademark
Application Date
RIXUBIS
RIXUBIS
85899949 4544829 Live/Registered
BAXALTA INCORPORATED
2013-04-10

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.